Company Monitoring Page for Takeda

latest headlines for company on cafepharma

J&J's Ethicon Spends $400M for Takeda’s Fibrin Sealant Patch
Medical Devices and Diagnostics Industry
Sat, 05/11/19 - 12:17 pm
Tags:
JNJ, Ethicon, M&A, Takeda, Fibrin Sealant Patch, surgical patch, TachoSil, devices
Takeda sells Shire’s Xiidra, transfers 400 staffers to Novartis in $3.4B deal
Fierce Pharma
Thu, 05/9/19 - 11:11 am
Tags:
Takeda, Shire, Novartis, M&A, Xiidra, dry eye disease
Novartis Considers Offer for Takeda Eye-Disease Assets
Bloomberg
Wed, 05/8/19 - 05:25 pm
Tags:
Novartis, Takeda, Shire, eye disease, M&A
Takeda’s Entyvio Ad Captures Struggle to Make Plans
Xtalks
Mon, 05/6/19 - 10:52 am
Tags:
Takeda, DTC ads, inflammatory bowel disease, Entyvio
Takeda Unites San Diego Operations At New ‘Biotech-Style’ R&D Center
Xconomy
Tue, 04/30/19 - 09:41 am
Tags:
Takeda, San Diego, biotech, R&D
Big Pharma come together for better drug side effect detection
Pharma Times
Sun, 04/7/19 - 05:18 pm
Tags:
side effects, adverse events, Pfizer, Roche, Takeda, Eli Lilly, Bristol-Myers Squibb, Gilead Sciences, Alexion, Celgene, International Working Group on Signal Detection and Management in Pharmacovigilance, pharmacovigilance
Takeda takes a cautious step into neurological gene therapy, inking preclinical deal with StrideBio
Endpoints
Sat, 03/30/19 - 12:10 am
Tags:
Takeda, StrideBio, gene therapy
Takeda’s Entyvio Bests Humira in Head-to-Head UC Study
BioSpace
Mon, 03/11/19 - 10:25 am
Tags:
Takeda, Entyvio, AbbVie, Humira, ulcerative colitis
14 Drugs Earn Billions for These Massachusetts Biotechs
BioSpace
Wed, 03/6/19 - 09:59 am
Tags:
Massachusetts, Boston, Biogen, Tecfidera, Benepali, Shire, Takeda, Vyvanse, Vertex Pharmaceuticals, Orkambi, Kalydeco, Alexion, Soliris, Strensiq, Sanofi Genzyme, Lantus, Ironwood Pharmaceuticals, Linzess
Takeda, Microsoft rare disease partnership publishes diagnosis roadmap
Fierce Pharma
Wed, 02/27/19 - 11:52 am
Tags:
Takeda, Microsoft, Eurodis, diagnosis, Rare Diseases
FDA Warns of Increased Risk of Death With Gout Medicine Uloric
RAPS.org
Fri, 02/22/19 - 10:05 am
Tags:
FDA, Uloric, Takeda, gout
NICE backs Takeda’s Alunbrig in second-line lung cancer
Pharmaforum
Sat, 02/16/19 - 12:02 am
Tags:
NICE, Takeda, Alunbrig, ALK-positive non-small cell lung cancer
Hurricanes, droughts, and wildfires: How biopharma is girding for climate change
Stat
Fri, 02/15/19 - 10:29 am
Tags:
climate change, natural disasters, tropical diseases, Takeda, AbbVie, Roche
Artificial Intelligence Gaining Ground in Drug Development
BioSpace
Mon, 02/11/19 - 10:00 am
Tags:
CASP, machine learning, artificial intelligence, drug development, Merck, Takeda, Atomwise, Bayer, GSK, Google DeepMind, Recursion Pharmaceuticals
Takeda's Hemophilia A Drug: New Data and a $155 Million Patent Infringement Settlement
BioSpace
Wed, 02/6/19 - 11:17 am
Tags:
Takeda, clinical trials, Adynovate, Baxalta, Bayer, patents
Q4 Biopharma Themes: Strong 2018, Weaker 2019 Earnings Projections, Concerns over Drug Pricing
BioSpace
Fri, 02/1/19 - 11:27 am
Tags:
earnings, Pfizer, Amgen, AbbVie, JNJ, Merck, Novo Nordisk, Takeda
Takeda's Phase III Dengue Vaccine Results Bring Them "One Step Closer" to Stopping Tropical Disease
BioSpace
Wed, 01/30/19 - 09:46 am
Tags:
Takeda, vaccines, dengue, tropical diseases
Last week in biopharma - earnings reports, drug pricing, a new GENE CEO and more
CP Wire
Sun, 01/27/19 - 07:09 pm
Tags:
earnings, drug pricing, Genentech, Eli Lilly, Medtronic, Roche, M&A, Takeda, GSK, FDA
Sun, 01/27/19 - 07:07 pm
Tags:
earnings, drug pricing, Genentech, Eli Lilly, Medtronic, Roche, M&A, Takeda, GSK, FDA
Is the Smoldering NASH Market Ready to Burst Into Flames?
BioSpace
Tue, 01/22/19 - 11:52 am
Tags:
NASH, Allergan, Regeneron, Alnylam, AstraZeneca, Merck, Takeda, Gilead Sciences, Bristol-Myers Squibb, Intercept Pharmaceuticals

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.